LivaNova (LIVN) Receivables - Other (2017 - 2025)
LivaNova recorded quarterly Receivables - Other of $600000.0 in Q4 2025, down 93.75% quarter-over-quarter from $9.6 million in Q2 2025, and down 81.82% year-over-year from $3.3 million in Q4 2024.
LivaNova's Receivables - Other history runs 4 years deep, the most recent figure standing at $600000.0 for Q4 2025.
- In Q4 2025, Receivables - Other fell 81.82% year-over-year to $600000.0; the TTM figure through Dec 2025 stood at $600000.0 (down 81.82% YoY), while the FY2025 annual figure was $600000.0, down 81.82% from the prior year.
- Receivables - Other came in at $600000.0 for Q4 2025 at LivaNova, down from $9.6 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $9.6 million in Q2 2025 to a low of $600000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 600,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Jun 30, 2025 | 9.60 Mn |
| Jun 30, 2025 | 9.60 Mn |
| Mar 31, 2025 | 8.60 Mn |
| Mar 31, 2025 | 8.60 Mn |
| Dec 31, 2024 | 3.30 Mn |
| Dec 31, 2024 | 3.30 Mn |
| Mar 31, 2018 | 2.00 Mn |
| Mar 31, 2018 | 2.00 Mn |
| Dec 31, 2017 | 1.00 Mn |
| Dec 31, 2017 | 1.00 Mn |
| Sep 30, 2017 | 4.06 Mn |
| Sep 30, 2017 | 4.06 Mn |
| Jun 30, 2017 | 4.82 Mn |
| Jun 30, 2017 | 4.82 Mn |